Login / Signup

The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark.

Peter BagerGry Juul PoulsenJan WohlfahrtMads Melbye
Published in: Allergy (2024)
Patients treated with pollen AIT in routine care to a higher degree stopped using anti-allergic nasal inhaler 0-5 years after starting the standard 3 years of therapy, and not beyond 5 years. Post hoc analyses suggested effectiveness was more consistent among patients with persistent AR.
Keyphrases
  • allergic rhinitis
  • randomized controlled trial
  • quality improvement
  • systematic review
  • healthcare
  • palliative care
  • stem cells
  • chronic rhinosinusitis
  • affordable care act
  • cell therapy
  • health insurance